The last twenty years have seen fundamental changes in how drug therapies are discovered, developed and marketed, with an accelerated rate of transformation in the industry realized in recent years with significant patent erosion, exponential increase of generics, and voids in blockbuster drug discoveries. In the face of these market pressures, traditional publicly traded drug companies are under ever-increasing pressure from shareholders to produce quick returns on investment.
The traditional pharmaceutical company will require a new paradigm for the business climate of the 21st century. Hallmarks of this business approach is a lean operation starting with effective project management coupled with crisp document production that ease qualification efforts and enhance speed to market.
The Pivotal Point Group offers program management services that assist physical consolidation efforts coupled with document/information retrieval systems that allow companies to put lean operations in place and enhance productivity.